HADCORP

Home

Implant Research

Dr Ostermeyer's Research

Neoplasms & Implants

Platinum Testing

Children and Silicone

About Breast Implants

Alternative Implants

Suicide and Implants

Implants and the FDA

Implants in the UK

Silicone Immune Protocol

Biotoxins

MCS

Implant Identification

Implant Photos

Orthopaedic Implants

Board of Directors

Medical Device News

Glossary

Implant Resources

Contact Us

Members
 

Knowledge Empowers   


 

Doris M. Kraemer et al.

| 12 | haematologica/the hematology journal | 2004; 89(online)

Lymphoplasmacytic lymphoma in a patient with leaking silicone implant

Haematologica 2004;89:(1)e12

To the Editor: We present the unusual case of a patient with leakage of a silicone implant, developing lymphoplasmacytic lymphoma.

A 55-year-old woman consulted us because of recurrent unexplained low grade fever since 1985. In 1977 the patient received silicone implants in both breasts. A mammography in 1992 showed a faint granular shadow, indicating leakage of the left silicone implant. Two years later, both breast implants were removed.

In March 2002 an enlarged lymph node in the left axilla was detected and subsequently excised. Histopatholgy specimens showed foreign body granulomas due to silicone without overt signs of malignant lymphoma (Figure 1a).

Physical examination in April 2002 showed no further enlarged lymph nodes. IgM was elevated up to 833 mg/dL (normal value <240 mg/dL). A work up of medical history indicated a slow increase of IgM during the last decade (1984: 237 mg/dl, 1991: 370 mg/dL, 1993: 577 mg/dL, 2001: 769 mg/dL, 2002: 833 mg/dL). Immune fixation showed a monoclonal IgM gammopathy of type kappa.

Bone marrow puncture revealed a 10% infiltration with lymphoma cells (Figure 1b). In flow cytometry lymphoma cells were CD19, HLA DR and CD27 positive, CD5 and CD10 negative. Therefore we diagnosed lymphoplasmacytic lymphoma. DNA was extracted from paraffin blocks and amplified using two primers (FR3A and LJH) recognizing the CDRIII region of the immunoglobulin heavy chain gene according standard protocols.1 Analysis of the PCR products by acrylamide gels run on an ABI Prism 377 using GeneScan 3.1 software, yielded monoclonal peaks of identical size (Figure 1c+d).

We think it is likely that leaking silicone stimulated the immune system of our patient as indicated by low grade fever. Symptoms of fever, chronic fatigue syndrome and connective tissue diseases have been reported for patients with silicone implants.2 Explantation of implants improved symptoms in over half of the patients.2

Induction of specific antibodies against a silicone surface associated antigen, has been described.3 A coincidence ofsilicone implants and multiple myeloma has been reported. 4 Furthermore induction of myeloma by injection of silicone into mice has been shown.5

In summary we propose that stimulation of the immune system by silicone led to the development of a malignant B-cell clone, which could not only be detected in the B-cells surrounding the foreign body granuloma in the draining lymph nodes of silicone implant, but which also infiltrated the bone marrow of our patient.

Figure 1. Histopathology specimen of the axillary lymph node showing foreign body granulomas (a) and specimen of bone marrow (b) indicating a peritrabecular pattern of infiltration with lymphoma cells. Electrophoretograms. Products of the polymerase chain reactions using primers recognizing the CDRIII region of the immunoglobulin heavy chain are shown in panel C (lymph node) and in panel D (bone marrow). The red line represents the size standard and the blue lines the tissue samples from the lymph node and bone marrow, respectively. Both types of tissue show a prominent monoclonal peak of about 82 bp (arrows).

*PD Dr. Doris M. Kraemer, *Prof. Dr. Hans-Peter Tony,

#Dr. Stefan Gattenlöhner and #PD Dr. Justus G. Müller

*Medizinische Poliklinik, University of Würzburg, Germany

#Institute of Pathology, University of Würzburg, Germany

Correspondence: PD Dr. med. Doris M. Kraemer Medizinische Poliklinik University of Würzburg Klinikstr. 8 97070 Würzburg Germany Phone: (49) 0931- 201 70030 Fax: (49) 0931- 201 70730 E-mail: d.kraemer@medizin.uni-wuerzburg.de

Acknowledgements: D.M. Kraemer is supported by grants

(Bayerischer Habilitationsförderpreis 2000,

Wilhelm Sander Stiftung 1999.119.2)

References

1. Derksen PW, Langerak AW, Kerkhof E, Wolvers-Tettero IL, Boor PP, Mulder AH, et al. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B- cell neoplasia. Mod Pathol 1999; 12:794-05.

2. Cuellar ML, Gluck O, Molina JF, Gutierrez S, Garcia C, Espinoza R. Silicone breast implant--associated musculoskeletal manifestations. Clin Rheumatol 1995; 14:667-72.

3. Kossovsky N, Gornbein JA, Zeidler M, Stassi J, Chun G, Papasian N, et al. Self-reported signs and symptoms in breast implant patients with novel antibodies to silicone surface associated antigens [anti-SSAA(x)] J Appl Biomater 1995; 6:153-60.

4. Silverman S, Vescio R, Silver D, Renner S, Weiner S, Berenson J. Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance. Curr Top Microbiol Immunol 1996; 210:367-74.

5. Potter M, Morrison S, Wiener F, Zhang XK, Miller FW. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. J Natl Cancer Inst 1994; 86:1058-65.

<<Back